In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

More than 700,000 Medicare beneficiaries currently face permanent increases in their Part B premiums because of late enrollment, with average penalties reaching 30 percent.

Medicare Part B drug negotiations in 2028 pose challenges for providers, requiring new payment systems and strategies to ...

Medicare Advantage may lure seniors with slick perks and shiny star ratings, but many soon find themselves tangled in red ...

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance ...